title: Are triple-negative tumours and basal-like breast cancer synonymous?
authors.forename: Emad A
authors.initials: EA
authors.lastname: Rakha
authors.forename: David S P
authors.initials: DS
authors.lastname: Tan
authors.forename: William D
authors.initials: WD
authors.lastname: Foulkes
authors.forename: Ian O
authors.initials: IO
authors.lastname: Ellis
authors.forename: Andrew
authors.initials: A
authors.lastname: Tutt
authors.forename: Torsten O
authors.initials: TO
authors.lastname: Nielsen
authors.forename: Jorge S
authors.initials: JS
authors.lastname: Reis-Filho
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000737:chemistry* / Q000473:pathology*; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D009361:Neoplasm Invasiveness; D020411:Oligonucleotide Array Sequence Analysis; D010641:Phenotype; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis
chemical_list: D014408:Biomarkers, Tumor; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone